Guardant Health Inc [GH] stock is trading at $46.46, down -1.73%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have lost -7.54% over the last week, with a monthly amount drifted -6.20%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on April 10, 2025, when Mizuho initiated its Outperform rating and assigned the stock a price target of $55. Previously, Barclays started tracking the stock with Overweight rating on January 23, 2025, and set its price target to $60. On June 28, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $36 on the stock. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
Guardant Health Inc [GH] stock has fluctuated between $20.14 and $53.42 over the past year. Currently, Wall Street analysts expect the stock to reach $61 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $46.46 at the most recent close of the market. An investor can expect a potential return of 31.3% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 774.00M for the trailing twelve months, which represents a growth of 20.76%. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.59%, Pretax Profit Margin comes in at -0.54%, and Net Profit Margin reading is -0.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 3.69 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -5.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.68 points at the first support level, and at 44.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 47.60, and for the 2nd resistance point, it is at 48.75.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 4.11. Further, the Quick Ratio stands at 3.76, while the Cash Ratio is 3.09. Considering the valuation of this stock, the price to sales ratio is 7.44.
Transactions by insiders
Recent insider trading involved Tariq Musa, Director, that happened on Jul 17 ’25 when 116.0 shares were sold. Director, POTTER MYRTLE S completed a deal on Jul 17 ’25 to sell 26.0 shares. Meanwhile, Director Tariq Musa bought 116.0 shares on Jul 17 ’25.
